recombinant erythropoiesis-stimulating protein

erythropoiesis-stimulating protein · Shenyang Sunshine Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant erythropoiesis-stimulating protein, covering 2022-01-27 to 2022-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure [Phase 3]

See pricing